The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124625652 12462565 2 F 20160719 20160614 20160722 EXP DE-ROCHE-1774952 ROCHE 0.00 F Y 55.00000 KG 20160722 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124625652 12462565 1 PS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) FIRST CYCLE?= 585 MG, 5 CYCLES, ACCORDING TO R-CHOP REGIMEN 103705 375 MG/M**2 SOLUTION FOR INFUSION Q3W
124625652 12462565 2 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 2ND CYCLE OF THE R-CHOP THERAPY 103705 SOLUTION FOR INFUSION
124625652 12462565 3 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 3RD CYCLE OF THE R-CHOP THERAPY 103705 SOLUTION FOR INFUSION
124625652 12462565 4 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 4 TH CYCLE OF THE R-CHOP THERAPY 103705 SOLUTION FOR INFUSION
124625652 12462565 5 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 5 TH CYCLE OF THE R-CHOP THERAPY 103705 SOLUTION FOR INFUSION
124625652 12462565 6 SS CYCLOPHOSPHAMID CYCLOPHOSPHAMIDE 1 Unknown FIRST CYCLE?5CYCLES, ACCORDING TO R-CHOP REGIMEN 0
124625652 12462565 7 SS CYCLOPHOSPHAMID CYCLOPHOSPHAMIDE 1 Unknown 2ND CYCLE OF THE CHOP THERAPY 0
124625652 12462565 8 SS CYCLOPHOSPHAMID CYCLOPHOSPHAMIDE 1 Unknown 3RD CYCLE OF THE CHOP THERAPY 0
124625652 12462565 9 SS CYCLOPHOSPHAMID CYCLOPHOSPHAMIDE 1 Unknown 4TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 10 SS CYCLOPHOSPHAMID CYCLOPHOSPHAMIDE 1 Unknown 5TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 11 SS HYDROXYDAUNORUBICIN DOXORUBICIN 1 Unknown FIRST CYCLE?5CYCLES, ACCORDING TO R-CHOP REGIMEN 0
124625652 12462565 12 SS HYDROXYDAUNORUBICIN DOXORUBICIN 1 Unknown 2ND CYCLE OF THE CHOP THERAPY 0
124625652 12462565 13 SS HYDROXYDAUNORUBICIN DOXORUBICIN 1 Unknown 3RD CYCLE OF THE CHOP THERAPY 0
124625652 12462565 14 SS HYDROXYDAUNORUBICIN DOXORUBICIN 1 Unknown 4TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 15 SS HYDROXYDAUNORUBICIN DOXORUBICIN 1 Unknown 5TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 16 SS VINCRISTIN VINCRISTINE 1 Unknown FIRST CYCLE?5CYCLES, ACCORDING TO R-CHOP REGIMEN 0
124625652 12462565 17 SS VINCRISTIN VINCRISTINE 1 Unknown 2ND CYCLE OF THE CHOP THERAPY 0
124625652 12462565 18 SS VINCRISTIN VINCRISTINE 1 Unknown 3RD CYCLE OF THE CHOP THERAPY. 0
124625652 12462565 19 SS VINCRISTIN VINCRISTINE 1 Unknown 4TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 20 SS VINCRISTIN VINCRISTINE 1 Unknown 5TH CYCLE OF THE CHOP THERAPY. 0
124625652 12462565 21 SS PREDNISOLON PREDNISOLONE 1 Unknown FIRST CYCLE?5CYCLES, ACCORDING TO R-CHOP REGIMEN 0
124625652 12462565 22 SS PREDNISOLON PREDNISOLONE 1 Unknown 2ND CYCLE OF THE CHOP THERAPY. 0
124625652 12462565 23 SS PREDNISOLON PREDNISOLONE 1 Unknown 3RD CYCLE OF THE CHOP THERAPY 0
124625652 12462565 24 SS PREDNISOLON PREDNISOLONE 1 Unknown 4TH CYCLE OF THE CHOP THERAPY 0
124625652 12462565 25 SS PREDNISOLON PREDNISOLONE 1 Unknown 5TH CYCLE OF THE CHOP THERAPY. 0
124625652 12462565 26 C COTRIMOXAZOL SULFAMETHOXAZOLETRIMETHOPRIM 1 Unknown 0 480 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124625652 12462565 1 Diffuse large B-cell lymphoma
124625652 12462565 6 Diffuse large B-cell lymphoma
124625652 12462565 11 Diffuse large B-cell lymphoma
124625652 12462565 16 Diffuse large B-cell lymphoma
124625652 12462565 21 Diffuse large B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
124625652 12462565 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
124625652 12462565 Progressive multifocal leukoencephalopathy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124625652 12462565 1 20151216 20160315 0
124625652 12462565 2 20160114 0
124625652 12462565 3 20160202 0
124625652 12462565 4 20160223 0
124625652 12462565 5 20160315 0
124625652 12462565 6 20151216 0
124625652 12462565 7 20160114 0
124625652 12462565 8 20160202 0
124625652 12462565 9 20160223 0
124625652 12462565 10 20160315 0
124625652 12462565 11 20151216 0
124625652 12462565 12 20160114 0
124625652 12462565 13 20160202 0
124625652 12462565 14 20160223 0
124625652 12462565 15 20160315 0
124625652 12462565 16 20151216 0
124625652 12462565 17 20160114 0
124625652 12462565 18 20160202 0
124625652 12462565 19 20160223 0
124625652 12462565 20 20160315 0
124625652 12462565 21 20151216 0
124625652 12462565 22 20160114 0
124625652 12462565 23 20160202 0
124625652 12462565 24 20160223 0
124625652 12462565 25 20160315 0
124625652 12462565 26 201603 0